Home

Cynosure 1Q profit more than doubles on laser product sales

By Associated Press
April 29, 2008 | Comments (0)

Recs

1

Cosmetic treatment equipment maker Cynosure Inc. said Tuesday its first-quarter profit more than doubled on strong demand for its aesthetic laser products.

The company earned $4.9 million, or 38 cents per share, compared with profit of $2.1 million, or 17 cents per share, in the year-ago period. Revenue rose 41 percent to $36.8 million from $26.1 million.

Analysts polled by Thomson Financial, on average, expected profit of 38 cents per share on revenue of $34.6 million.

Laser product revenue increased 43 percent in the quarter, led by sales of the company's Smartlipo laser lipolysis workstation and Affirm anti-aging platform.

Shares rose 95 cents, or 3.9 percent, to $25.17 in morning trading.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

DocumentId: 632406, ~/articles/articlehandler.aspx, 12/2/2008 6:05:54 AM,

Sign up for FREE Motley Fool site access to keep reading:

“Cynosure 1Q profit more than doubles on laser product sales”

Signing up allows you to comment on articles and on the discussion boards.

It's completely FREE and will take only 10 seconds.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.